Company intelligence / Profile preview

American Resiliency

La Jolla, California, USAamericanresiliency.org ↗

Ownership: Private
Development stage: Other

Overview

Resilience provides advanced biomanufacturing services supporting clinical and commercial production of complex medicines. It has manufactured GLP‑1 drugs for Eli Lilly and collaborates with Mayo Clinic on cell therapy development. Recent restructuring has led to facility closures but continued focus on high-growth segments like biologics and aseptic drug product operations

Modalities: BiologicVaccineGene therapyCell therapyNucleic acid therapy
Industry: Contract Manufacturing Organization

Partnerships

Eli Lilly (GLP‑1 drug manufacturing)Mayo Clinic Center for Regenerative Medicine (cell/gene therapy collaboration)Aralez Bio (API supply chain partnership)Takeda and AstraZeneca have been mentioned as past clients/contracts

Beyond the preview

Go deeper on American Resiliency.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American Resiliency.

Explore the full profile